abstract |
The present disclosure provides COL5A2-ALK fusion nucleic acid molecules and polypeptides, and COL3A1-ALK fusion nucleic acid molecules and polypeptides, as well as methods, kits and reagents for detecting such fusion nucleic acid molecules and polypeptides. The disclosure also provides methods for evaluating, identifying, assessing, and/or treating an individual having a cancer. |